Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
2020 ◽
Vol 61
(8)
◽
pp. 1850-1859
Katja Weisel
◽
Meletios Dimopoulos
◽
Philippe Moreau
◽
Munci Yagci
◽
Alessandra Larocca
◽
...
2014 ◽
Vol 100
(2)
◽
pp. e63-e67
◽
K. W. Song
◽
M. A. Dimopoulos
◽
K. C. Weisel
◽
P. Moreau
◽
A. Palumbo
◽
...
Torben Plesner
◽
Meletios A. Dimopoulos
◽
Albert Oriol
◽
Jesus San‐Miguel
◽
Nizar J. Bahlis
◽
...
D.S. Siegel
◽
K. Weisel
◽
A. Zahlten-Kumeli
◽
R. Medhekar
◽
S. Sapra
◽
...
2019 ◽
Vol 3
(S1)
◽
pp. 268-269
D. Reece
◽
N.J. Bahlis
◽
C. Samaras
◽
M. Sebag
◽
J. Berdeja
◽
...
Vania Hungria
◽
Meral Beksac
◽
Katja C. Weisel
◽
Ajay K. Nooka
◽
Tamas Masszi
◽
...
2018 ◽
Vol 97
(12)
◽
pp. 2455-2463
◽
David Cella
◽
Jan McKendrick
◽
Amber Kudlac
◽
Antonio Palumbo
◽
Abderrahim Oukessou
◽
...
2015 ◽
Vol 15
◽
pp. e176-e177
X. Leleu
◽
I.V. Broek
◽
C. Kyriakou
◽
P. Murphy
◽
P. Bacon
◽
...
2017 ◽
Vol 17
(1)
◽
pp. e87
Dan T. Vogl
◽
Michel Delforge
◽
Kevin Song
◽
Shien Guo
◽
Craig J. Gibson
◽
...
2019 ◽
Vol 3
(S1)
◽
pp. 261-262
◽
L. Rosiñol
◽
E.M. Ocio
◽
M. Grande
◽
A. Fernandez-Nistal
◽
A. Ruiz-Zorrilla
◽
...
2015 ◽
Vol 100
(6)
◽
pp. 826-833
◽
M. Delforge
◽
L. Minuk
◽
J.-C. Eisenmann
◽
B. Arnulf
◽
L. Canepa
◽
...
Close
Export Citation Format
Close
Share Document
Close